VSIR and neoplasm: VISTA expression is enhanced on tumor-infiltrating MDSCs and linked to areas of severe hypoxia in the TME, and antibodies targeting or genetically ablating VISTA under hypoxia alleviate MDSCs-induced T-cell suppression [49].